ESTROGEN REPLACEMENT THERAPY AND FIBROCYSTIC BREAST DISEASE IN POSTMENOPAUSAL WOMEN

[31] EPIDEMIOLOGY OF BENIGN BREAST LESIONS - LACK OF ASSOCIATION WITH ORAL-CONTRACEPTIVE USE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (11) : 551 - 554

[32] Scharf G, 1941, P SOC EXP BIOL MED, V48, P86, DOI 10.3181/00379727-48-13228

[33] SITRUKWARE R, 1979, OBSTET GYNECOL, V53, P457

[34] SLOSS PT, 1957, AM J PATHOL, V33, P1181

[35] YOSHIDA H, 1981, GANN, V72, P315

[36] 1974, N ENGL J MED, V290, P15

[31] EPIDEMIOLOGY OF BENIGN BREAST LESIONS - LACK OF ASSOCIATION WITH ORAL-CONTRACEPTIVE USE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (11) : 551 - 554

[32] Scharf G, 1941, P SOC EXP BIOL MED, V48, P86, DOI 10.3181/00379727-48-13228

[33] SITRUKWARE R, 1979, OBSTET GYNECOL, V53, P457

[34] SLOSS PT, 1957, AM J PATHOL, V33, P1181

[35] YOSHIDA H, 1981, GANN, V72, P315

[36] 1974, N ENGL J MED, V290, P15